GENOMIC AND PROTEOMIC ANALYSIS OF PHI32, A NOVEL ESCHERICHIA COLI PHAGE

新型大肠杆菌噬菌体 PHI32 的基因组和蛋白质组分析

• 批准号: 8169150
• 负责人: KONSTANTIN V SEVERINOV
• 金额: $ 0.23万
• 依托单位: ROCKEFELLER UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-03-01 至 2011-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8169150
• 关键词: Bacteriophages; Binding Proteins; Cattle; Coliphages; Computer Retrieval of Information on Scientific Projects Database; DNA-Directed RNA Polymerase; Electron Microscopy; Escherichia coli; Family; Funding; Genetic Transcription; Genome; Genomics; Grant; Institution; Names; Planet Mars; Proteins; Proteomics; Research; Research Personnel; Resources; Sigma Factor; Source; United States National Institutes of Health; Viral Genes; Virion; inhibitor/antagonist; mastitis; novel

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A novel phage infecting Escherichia coli was isolated during a large-scale screen for phages that may be used for therapy of mastitis in cattle. The 77,554 bp genome of the phage, named phi32, was sequenced and annotated, and its virions were characterized by electron microscopy and proteomics. Two phi32-encoded proteins that interact with host RNA polymerase were identified. One of them is an ECF-family sigma-factor that may be responsible for transcription of some viral genes. Another RNA polymerase-binding protein is a novel transcription inhibitor whose mechanism of action remains to be defined. Genomic and proteomic analysis of phiEco32, a novel Escherichia coli bacteriophage. Savalia D, Westblade LF, Goel M, Florens L, Kemp P, Akulenko N, Pavlova O, Padovan JC, Chait BT, Washburn MP, Ackermann HW, Mushegian A, Gabisonia T, Molineux I, Severinov K. J Mol Biol. 2008 Mar 28;377(3):774-89.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 在大规模筛选中，分离出一种新型的噬菌体感染大肠杆菌，用于噬菌体，该噬菌体可用于治疗牛的乳腺炎。对噬菌体的77,554 bp基因组进行了测序和注释，其病毒体的特征是电子显微镜和蛋白质组学。鉴定了两种与宿主RNA聚合酶相互作用的PHI32编码蛋白。其中之一是一种ECF家庭的Sigma因子，可能导致某些病毒基因的转录。另一种RNA聚合酶结合蛋白是一种新型的转录抑制剂，其作用机理仍有待定义。 PHIECO32的基因组和蛋白质组学分析，这是一种新型大肠杆菌噬菌体。 Savalia D，Westblade LF，Goel M，Florens L，Kemp P，Akulenko N，Pavlova O，Padovan JC，Chait BT，Washburn MP，Ackermann HW，Mushegian A，Gabisonia A，Gabisonia T，Molineux I，Severinov K. Severinov K. J Mol Biol。 2008年3月28日； 377（3）：774-89。